Name (Synonyms) | Correlation | |
---|---|---|
drug933 | Odd/Even birth year intervention groups Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.06 |
D018352 | Coronavirus Infections NIH | 0.05 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This is an open label, randomized, controlled, pilot clinical study in patients with COVID-19, to obtain preliminary biologic, physiologic, and clinical data in patients with COVID-19 treated with rhACE2 or control patients, to help determine whether a subsequent Phase 2B trial is warranted.
Description: Compare the time course of body temperature (fever) between two groups over time.
Measure: Time course of body temperature (fever) Time: 14 daysDescription: Compare viral load between two groups over time.
Measure: Viral load over time Time: 14 daysDescription: PaO2/FiO2 ratio
Measure: P/F ratio over time Time: 14 daysDescription: SOFA, including assessment of respiratory, blood, liver, circulatory, nerve, kidney, from 0 to 4 scores in each systems, the higher scores mean a worse outcome.
Measure: Sequential organ failure assessment score(SOFA score) over time Time: 14 daysDescription: Based on radiologist's assessment of inflammatory exudative disease, category as follows: significant improvement, partial improvement, no improvement, increase of partial exudation, significant increase in exudation, unable to judge.
Measure: Image examination of chest over time Time: 14 days